Paul Andrea
Insider CIK 1863130 · LOGC General Counsel and Secretary · ZNTL General Counsel
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ZNTL Zentalis Pharmaceuticals, | A Award deriv | 2025-02-03 | 2025-02-05 | 124,714 | — | $0 | 124,714 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2025-02-03 | 2025-02-05 | 13,230 | $1.71 | $22.6K | 1,070,784 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | A Award | 2025-02-03 | 2025-02-05 | 934,041 | — | $0 | 1,084,014 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2024-02-02 | 2024-02-05 | 3,310 | $11.54 | $38.2K | 149,973 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | A Award deriv | 2024-02-01 | 2024-02-05 | 112,500 | — | $0 | 112,500 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | A Award deriv | 2024-02-01 | 2024-02-05 | 90,000 | — | $0 | 90,000 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | A Award | 2024-02-01 | 2024-02-05 | 112,500 | — | $0 | 153,283 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | A Award deriv | 2023-02-01 | 2023-02-01 | 59,217 | — | $0 | 59,217 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | A Award | 2023-02-01 | 2023-02-01 | 40,783 | — | $0 | 40,783 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | A Award deriv | 2022-08-01 | 2022-08-01 | 290,500 | — | $0 | 290,500 | SEC↗ |
| LOGC LogicBio Therapeutics, Inc | A Award deriv | 2022-03-01 | 2022-03-03 | 80,000 | — | $0 | 80,000 | SEC↗ |
| LOGC LogicBio Therapeutics, Inc | A Award deriv | 2021-05-17 | 2021-05-19 | 165,000 | — | $0 | 165,000 | SEC↗ |